Gyntech SRL
Gyntech reported total assets of 20,358 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Gyntech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gyntech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Gyntech's financial analysis
- Solvency-149.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gyntech
Gyntech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.381.089
- VAT number
- BE0429381089
- Peppol
- Registered · 0208:0429381089 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Aug 1986
- Registered office
- 2140 Antwerp
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Gyntech (SRL) has been based in Antwerp since 1986, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 3,339 € and equity of −30,477 €; its revenue is not published. Its solvency stands at -149.7%, below the median of its sector (46.0%).
Companies similar to Gyntech
Companies in the same business, of comparable size and area, outside its group.
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Maximize Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 20,065 €
- Medicode Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 63,460 €
- Medidat Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 57,897 €
- Globex International Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 92,829 €
- Nature Avenue Wholesale of pharmaceutical and medical goods Lier · balance sheet 105,922 €
- Lopital België Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 120,231 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
Frequently asked questions about Gyntech
What is the revenue of Gyntech?
Gyntech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gyntech?
In Belgium, the VAT number is the company number prefixed with BE: BE0429381089 for Gyntech, if the company is VAT-registered. Its company number (CBE) is 0429.381.089.
Where is the registered office of Gyntech?
According to the CBE register, the registered office of Gyntech is in 2140 Antwerp.
What is the equity of Gyntech?
At the close of the 2025 financial year, the equity of Gyntech amounts to -30,477 €, a solvency of -149.7% of total assets.
Who manages Gyntech?
The register lists 1 active mandates at Gyntech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gyntech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →